Clinical Trials · NCT00912548

Evaluating the Role of the Addition of Ovarian Function Suppression (OFS) to Tamoxifen in Young Women

UnknownPhase 3Gonadorelin (Unclear)
Phase
Phase 3
Recruitment status
Unknown
Sponsor
Korean Breast Cancer Study Group
Enrollment
1,234
Start date
May 2009
Locations
1 site, South Korea
Primary endpoint
all cause recurrence
View Gonadorelin compound reference